Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic ...
A federal court rejected Novartis Pharmaceuticals’, a unit of Novartis AG (NYSE:NVS) legal challenge to the Medicare Drug ...
The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug price negotiation program enacted under President Joe Biden. | The Trump ...
The Inflation Reduction Act of 2022 marked a significant shift in US health care policy, granting the Centers for Medicare and Medicaid Services (CMS) the authority to establish a program to negotiate ...
Everyone is talking about or using weight loss products. So, the government pounces. A batch of 17 drugs are on a list of ...
However, there has been one notable exception: the Medicare Drug Price Negotiation Program — although they’re leaving room for some potential changes. The program, created under the Inflation ...
Records show that drug companies gave nearly $75,000 to the top Republican and Democrat on a committee investigating them.
The court ruled that Novartis is not legally compelled to participate in the Medicare Drug Price Negotiation Program. The decision reaffirmed that the program does not constitute excessive fines ...
Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government ...